7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-09-30 2018-06-31 2018-03-31 
      
    		                              
      cash flows from operating activities:
    		                              
      net income
    		-33,516,000 -30,013,000 -20,504,000 -11,628,000 -7,358,000 -9,473,000 -10,072,000 -12,409,000 -7,758,000 -6,064,000 -6,103,000 -18,581,000 -35,064,000 -24,902,000 -18,153,000 -20,026,000 -15,661,000 -11,897,000 -10,104,000 -9,821,000 2,203,000 -12,302,000 -11,610,000 -10,958,000 -9,870,000 -10,563,000 -9,405,000 -7,657,000 -7,343,000 -7,202,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                              
      depreciation and amortization expense
    		5,431,000 1,999,000 2,188,000 1,723,000 1,616,000 1,601,000 1,523,000 1,576,000 1,943,000 1,406,000 1,439,000 1,163,000 1,396,000 1,432,000 1,358,000 1,285,000 1,222,000 1,193,000 1,151,000 1,125,000 1,108,000 1,033,000 1,046,000 821,000 1,235,000 544,000 409,000 411,000 337,000 272,000 
      credit losses on accounts receivable
    		546,000 -315,000 53,000  68,000 500,000 176,000  -13,000                      
      accretion of marketable securities
    		-284,000 -588,000 -979,000 -1,516,000 -1,698,000 -1,962,000 -1,657,000                        
      impairment
    		                              
      operating lease right-of-use asset amortization
    		1,208,000 289,000 561,000 522,000 531,000 362,000 478,000 497,000 516,000                      
      stock-based compensation expense
    		5,469,000 5,372,000 5,462,000 4,837,000 4,657,000 5,228,000 5,265,000 4,326,000 4,343,000 4,193,000 3,902,000 3,663,000 2,766,000 5,186,000 3,827,000 4,931,000 4,008,000 3,650,000 3,386,000 3,129,000 2,360,000 2,501,000 2,109,000 1,675,000 1,828,000 1,601,000 1,284,000 1,867,000 890,000 636,000 
      change in fair value of contingent liabilities
    		                              
      deferred taxes
    		          207,000                    
      other operating activity
    		294,000 42,000 -412,000 444,000 -376,000 -68,000 55,000                        
      changes in assets and liabilities:
    		                              
      accounts receivable
    		-1,575,000 5,147,000 4,329,000 -1,302,000 840,000 -3,009,000 -4,233,000 -1,080,000 135,000 -2,077,000 -3,673,000 111,000 1,566,000 2,160,000 1,319,000 -5,297,000 -3,296,000 -487,000 2,227,000 9,120,000 -16,805,000 2,619,000 -1,174,000 1,109,000 -2,178,000   -1,063,000 1,075,000 1,148,000 
      inventory
    		1,211,000 908,000 2,085,000 166,000 -834,000 -2,341,000 -3,670,000 -2,398,000 -1,785,000 -1,092,000 -89,000 1,467,000 3,739,000 664,000 -484,000 341,000 -1,638,000 -4,466,000 -2,327,000 -1,614,000 -1,000 -2,106,000 -1,398,000 496,000 -1,038,000      
      prepaid expenses and other current assets
    		256,000 1,521,000 421,000 -275,000 -765,000 851,000 -254,000 458,000 -2,302,000                      
      other non-current assets
    		257,000 355,000 -502,000 -736,000 117,000 -575,000 -21,000 -59,000 249,000 -932,000 -33,000 -50,000 -861,000 1,000 1,000 1,000 17,000 -4,000 -16,000 16,000 155,000 -5,000 32,000 0 -23,000 -1,000 3,000    
      accounts payable
    		-6,333,000 2,397,000 399,000 135,000 -1,466,000 3,176,000 -1,122,000 241,000 1,579,000 640,000 -1,271,000 1,723,000 -3,865,000 2,086,000 -5,306,000 3,386,000 -1,012,000 2,149,000 -2,109,000 836,000 772,000 186,000 -1,145,000 1,456,000 765,000      
      accrued compensation and benefits, accrued expenses, and other current liabilities
    		-7,452,000 5,122,000 -3,517,000 4,564,000 1,224,000 1,736,000 -6,126,000 3,400,000 2,202,000                      
      deferred revenue
    		-1,109,000 284,000 299,000 32,000 -1,180,000 -118,000 472,000 -259,000 -772,000 -375,000 2,041,000 -509,000 -3,120,000 3,272,000 2,956,000 788,000 -217,000 -306,000 1,197,000 1,842,000 -1,248,000 -430,000 671,000 -104,000 -294,000 -355,000 45,000    
      operating lease liabilities
    		-1,945,000 -901,000 -1,157,000 -1,104,000 -1,095,000 -888,000 -988,000 -955,000 -960,000 -909,000 179,000 890,000 1,972,000 -3,041,000 -87,000 -328,000 -312,000 -283,000 -307,000 -199,000 128,000 134,000 253,000        
      other non-current liabilities
    		1,134,000 625,000 -2,993,000 -8,000 -28,000 29,000 10,000 54,000 -35,000 131,000 -203,000 -118,000 137,000 262,000 -271,000 -255,000   -107,000 -311,000 260,000 -260,000 -177,000 -223,000 620,000 3,366,000 6,082,000    
      net cash from operating activities
    		-41,249,000 -5,655,000 -13,888,000 -4,302,000 -5,747,000 -4,951,000 -20,164,000 -5,984,000 -4,049,000 633,000 -9,502,000 -4,090,000 -14,547,000 -7,940,000 -21,695,000 -10,292,000 -13,777,000 -9,749,000 -14,089,000 4,654,000 -7,419,000 -7,421,000 -13,179,000 -4,535,000 -8,832,000      
      capex
    		-953,000 -794,000 -734,000 -412,000 -1,031,000 -859,000 -284,000 -2,216,000 -788,000 -648,000 11,000 -1,595,000 -3,677,000 -5,060,000 -1,394,000 -2,530,000 -3,824,000 -9,712,000 3,262,000 -1,110,000 -465,000 -1,002,000 -324,000 -603,000 -1,014,000      
      free cash flows
    		-42,202,000 -6,449,000 -14,622,000 -4,714,000 -6,778,000 -5,810,000 -20,448,000 -8,200,000 -4,837,000 -15,000 -9,491,000 -5,685,000 -18,224,000 -13,000,000 -23,089,000 -12,822,000 -17,601,000 -19,461,000 -10,827,000 3,544,000 -7,884,000 -8,423,000 -13,503,000 -5,138,000 -9,846,000      
      cash flows from investing activities:
    		                              
      purchases of marketable securities
    		-15,413,000 1,000 -30,246,000  -81,628,000 -51,455,000 -137,889,000                        
      proceeds from sales and maturities of marketable securities
    		47,515,000 62,613,000 73,261,000                            
      purchases of property and equipment
    		-677,000 -777,000 -1,256,000 -412,000 -851,000 -1,599,000 -506,000 -2,216,000 -788,000 -648,000 -136,000 -1,595,000 -3,677,000 -5,060,000 -1,394,000 -2,453,000 -3,824,000 -7,260,000 -79,000 -1,781,000 -788,000 -935,000 -426,000 -544,000 -473,000      
      acquisitions, net of cash acquired
    		                       0       
      net cash from investing activities
    		-52,850,000 61,880,000 32,762,000 32,384,000 -12,429,000 6,975,000 -109,195,000 -21,629,000 -125,988,000 -648,000 -136,000 -1,595,000 -3,677,000 -5,060,000 -874,000 -2,194,000 -2,015,000 -4,564,000 2,435,000 1,523,000 -788,000 -935,000 -426,000 -544,000 -15,002,000 -3,913,000 -5,917,000    
      cash flows from financing activities:
    		                              
      principal payments on financing leases
    		                              
      proceeds from common stock issued under stock plans
    		262,000 0 668,000 67,000 578,000 384,000 2,037,000 257,000 1,855,000                      
      payments for employee taxes withheld on stock-based compensation awards
    		-6,000 -429,000 -575,000 -26,000 -434,000 -712,000 -1,438,000 -56,000 -55,000                      
      net cash from financing activities
    		150,000 -429,000 93,000 41,000 144,000 -328,000 599,000 201,000 1,800,000 139,000 551,000 714,000 407,000 211,000 979,000 -851,000 -4,060,000 2,393,000 273,313,000 2,076,000 92,684,000 615,000 861,000 724,000 65,201,000      
      net increase in cash, cash equivalents, and restricted cash
    		-93,949,000 55,796,000 18,967,000                            
      effect of exchange rate changes on cash, cash equivalents, and restricted cash
    		46,000 594,000 861,000 -752,000 371,000 27,000 -380,000 530,000 -66,000                      
      cash, cash equivalents, and restricted cash at beginning of period
    		0 0 59,319,000 0 0 0 177,026,000 0 0                      
      cash, cash equivalents, and restricted cash at end of period
    		-93,903,000 56,390,000 79,147,000 27,371,000 -17,661,000 1,723,000 47,886,000 -26,882,000 -128,303,000                      
      supplemental disclosure of cash flow information:
    		                              
      equity consideration transferred in connection with the acquisition of akoya
    		                              
      cash paid for taxes
    		405,000 385,000 505,000 172,000 189,000 339,000 175,000 89,000 217,000                      
      right-of-use assets obtained in exchange for lease liabilities
    		                              
      purchases of property and equipment in accounts payable and accrued expenses
    		-276,000 -17,000 522,000  -180,000 740,000 222,000                        
      impairment of goodwill
    		                              
      change in fair value of contingent consideration
    		 -4,273,000 379,000                            
      acquisition, net of cash acquired
    		 43,000 -8,997,000                            
      right-of-use asset obtained in exchange for lease liabilities
    		           255,000   18,156,000                
      credit losses (gains) on accounts receivable
    		                              
      purchases of marketable debt securities
    		                              
      proceeds from maturities of marketable securities
    		   57,430,000 70,050,000 60,029,000 29,200,000                        
      proceeds from radx grant on assets purchased
    		           0 0 0 520,000 259,000 1,809,000 2,696,000 2,514,000            
      net decrease in cash, cash equivalents, and restricted cash
    		   28,123,000 -18,032,000 1,696,000 -128,760,000  -128,237,000                      
      purchases of property and equipment in accounts payable and accruals
    		                              
      operating lease right-of-use assets obtained in exchange for lease liabilities
    		                              
      non-cash consideration received under product sales agreement
    		                              
      shares received as consideration under product sales agreement
    		        -225,000                      
      ​
    		                              
      proceeds from marketable debt securities
    		                              
      sale of common stock in underwritten public offering
    		               0 0 0 269,718,000 0           
      payments on notes payable
    		               -1,994,000    0 0 0 -75,000 0 0      
      cash paid for interest
    		               0 80,000 155,000 154,000 157,000 313,000 0 155,000 178,000 318,000 0 160,000 159,000 166,000 181,000 
      foreign currency losses
    		        154,000                      
      unrealized losses on marketable securities
    		                              
      amortization of (discount) premium on marketable securities
    		                              
      deferred income taxes
    		        -101,000                      
      loss on disposal of fixed assets
    		                    51,000 0 69,000  10,000      
      operating activities
    		                              
      credit (income) loss expense on accounts receivable
    		          110,000                    
      unrealized losses (gains) on foreign currency transactions
    		          63,000                    
      non-cash operating lease expense
    		          334,000                    
      changes in operating assets and liabilities:
    		                              
      prepaid expenses and other assets
    		          -422,000 -306,000 -1,192,000 3,000,000 -2,070,000 1,002,000 1,557,000 -1,208,000 -1,744,000 -3,922,000 -121,000 611,000 -495,000 393,000 -406,000 160,000 142,000    
      accrued compensation and benefits, other accrued expenses and other current liabilities
    		          -5,983,000 -955,000 1,366,000 534,000 -4,921,000 3,798,000 1,188,000 1,673,000 -5,598,000 4,102,000 3,125,000 702,000 -1,710,000 249,000 -96,000      
      investing activities
    		                              
      financing activities
    		                              
      proceeds from stock options exercised
    		          13,000 714,000 120,000 211,000 385,000 1,143,000 1,138,000 2,393,000 3,076,000 2,076,000 832,000 615,000 496,000 644,000 266,000 1,407,000 503,000 303,000 297,000 84,000 
      proceeds from espp purchase
    		          551,000 0 287,000 0 594,000 0 546,000 0 519,000 0 448,000 0 440,000 80,000 406,000 65,000 328,000    
      payments for employee taxes on units withheld
    		          -13,000                    
      net increase in cash, cash equivalents and restricted cash
    		          -9,087,000  -17,817,000 -12,789,000 -21,590,000                
      effect of foreign currency exchange rate on cash
    		          24,000 -31,000 269,000 -218,000 -558,000 -26,000 77,000 28,000 -171,000 169,000 -121,000 188,000 -78,000 183,000       
      cash, cash equivalents and restricted cash at beginning of period
    		          341,337,000                    
      cash, cash equivalents and restricted cash at end of period
    		          332,274,000                    
      cash paid for income taxes
    		          246,000                    
      noncash transactions:
    		                              
      purchases of property and equipment included in accounts payable and accrued expenses
    		          147,000                    
      reconciliation of cash, cash equivalents and restricted cash:
    		                              
      cash and cash equivalents
    		          329,354,000 -5,003,000 -17,550,000 -13,024,000 374,317,000 -14,282,000 -20,033,000 -11,892,000 442,672,000 8,422,000 84,356,000 -7,553,000 96,359,000 -4,172,000 41,302,000 38,053,000 33,972,000    
      restricted cash
    		          2,920,000 1,000 2,000 17,000 2,577,000 919,000 258,000 0 1,400,000 0 0 0 1,000,000 0 0 7,000 1,019,000    
      total cash, cash equivalents, and restricted cash
    		          332,274,000 -5,002,000 -17,548,000 -13,007,000 376,894,000 -13,363,000 -19,775,000 -11,892,000 444,072,000 8,422,000 84,356,000 -7,553,000 97,359,000 -4,172,000 41,302,000 38,060,000 34,991,000    
      inventory step-up amortization
    		               0 0 111,000 164,000 52,000 476,000 -244,000 438,000        
      non-cash lease expense
    		                              
      goodwill impairment
    		           0                   
      impairment of long-lived assets
    		                              
      non-cash interest expense
    		               0 22,000 21,000 22,000 21,000 22,000 21,000 22,000 21,000 22,000 22,000 24,000 34,000 46,000 53,000 
      net increase in cash and cash equivalents
    		               -13,337,000 -19,852,000 -11,920,000 261,659,000 8,253,000 84,477,000   -4,355,000 41,367,000      
      cash, restricted cash, and cash equivalents at beginning of period
    		             0 399,042,000 0 0 0 182,584,000 0 0 0 110,181,000 0 0 0 45,429,000    
      cash, restricted cash, and cash equivalents at end of period
    		             -13,007,000 376,894,000 -13,363,000 -19,775,000 -11,892,000 444,072,000 8,422,000 84,356,000 -7,553,000 97,359,000 -4,172,000 41,302,000 38,060,000 34,991,000    
      supplemental cash flow information
    		                              
      purchases of property and equipment included in accounts payable and other accrued expenses
    		               -77,000               
      reconciliation of cash, cash equivalents, and restricted cash:
    		                              
      credit loss expense on accounts receivable
    		            -479,000 752,000 -171,000 -73,000 266,000 0 20,000            
      impairment expense
    		                              
      other non-cash items
    		                              
      cash, cash equivalents and restricted stock at beginning of period
    		                              
      cash, cash equivalents and restricted stock at end of period
    		                              
      reduction in the carrying amount of right-of-use assets
    		             577,000 348,000                
      contract acquisition costs
    		             71,000 -41,000 -69,000 -51,000 0 -72,000 186,000 0 11,000 -110,000 -197,000 593,000      
      reduction in the carrying amounts of right-of-use assets
    		               135,000 118,000 118,000 128,000 41,000 96,000          
      sale of common stock in at-the-market offering
    		                              
      purchase of property and equipment included in other non-current liabilities
    		                              
      common stock issued in connection with the acquisition of umandiagnostics ab
    		                              
      deferred tax liabilities
    		                              
      purchases of property and equipment included in accounts payable
    		                 -2,452,000 3,341,000 671,000 323,000 -67,000 102,000 119,000 -234,000 268,000 11,000    
      gain on disposal of fixed assets
    		                              
      purchase of investments
    		                              
      proceeds from sale of assets
    		                              
      proceeds from sale of common stock, net of issuance costs
    		                              
      purchases of property and equipment included in other non-current liabilities
    		                       -178,000 -307,000      
      191,152 shares of common stock issued in connection with the acquisition of umandiagnostics ab
    		                              
      fair value of common stock warrants exercised and reclassified as shares of common stock
    		                              
      acquisition of umandiagnostics ab, net of cash acquired
    		                              
      net decrease in cash and cash equivalents
    		                      -12,744,000        
      inventory valuation adjustment amortization
    		                              
      change in fair value of preferred stock warrants
    		                              
      deposits
    		                              
      proceeds from sale of preferred stock, net of issuance costs
    		                              
      proceeds from exercise of stock warrants
    		                              
      proceeds from the issuance of notes payable and warrants, net of issuance costs
    		                              
      accretion of redeemable convertible preferred stock to redemption value
    		                              
      warrants issued to lenders
    		                              
      net proceeds from at-the-market offering
    		                        0      
      net proceeds from underwritten public offering
    		                              
      191,152 shares of common stock issued in connection with the acquisition of uman
    		                              
      net cash provided (used in) by financing activities
    		                          831,000    
      accrued compensation and benefits, other accrued expenses and other liabilities
    		                              
      proceeds from the issuance of long term debt and warrants, net of issuance costs
    		                              
      payments on long term debt
    		                              
      cash and cash equivalents at beginning of period
    		                            0 79,682,000 
      cash and cash equivalents at end of period
    		                            -4,757,000 65,231,000 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.